Urinary and Sexual Impact of Robotic Radical Prostatectomy: Reporting of Patient-reported Outcome Measures in the First Year after Radical Prostatectomy in a Contemporary Multicentre Cohort in the United Kingdom

被引:9
作者
Bridge, Joshua [1 ,2 ]
Labban, Muhieddine [3 ,4 ]
Cole, Alexander P. [3 ,4 ]
Adebusoye, Busola [1 ,2 ]
Smith, Sarah C. [5 ]
Protopapa, Evangelia [5 ]
Mccartan, Neil [1 ,6 ]
Brew-Graves, Chris [1 ,2 ]
Trinh, Quoc-Dien [3 ,4 ]
Hamer, Kevin [7 ]
Mallett, Sue [2 ]
van der Meulen, Jan [5 ]
Moore, Caroline M. [1 ,8 ,9 ]
机构
[1] UCL, Div Surg & Intervent Sci, London, England
[2] UCL, Div Med, Natl Canc Imaging Translat Accelerator, London, England
[3] Harvard Med Sch, Brigham & Womens Hosp, Div Urol Surg, Boston, MA USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA USA
[5] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England
[6] Our Future Hlth, London, England
[7] Univ Hosp Southampton, Med Records, Southampton, England
[8] Univ Coll London Hosp Trust, Dept Urol, London, England
[9] UCL, Div Surg & Intervent Sci, London, England
来源
EUROPEAN UROLOGY OPEN SCIENCE | 2024年 / 64卷
关键词
Prostate cancer; Patient-reported outcome; measures; Radical prostatectomy; QUALITY-OF-LIFE; CANCER;
D O I
10.1016/j.euros.2024.05.003
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Radical prostatectomy (RP) is an established treatment for localised prostate cancer that can have a significant impact on urinary and sexual function, with recovery over time. Our aim was to describe functional recovery in the first year after RP, reporting descriptive outcomes alongside validated patient-reported outcome measure scores (Expanded Prostate Cancer Index Composite, EPIC-26). Methods: Men undergoing RP between September 2015 and November 2019 completed EPIC-26 at baseline and 1, 3, 6, and 12 mo. Key findings and limitations: Overall, 2030 men consented to participation, underwent RP, and completed EPIC-26. At baseline, 97% were pad-free (1928/1996; 95% confidence interval [CI] 96-97%) and 77% were leak-free and pad-free (1529/1996; 95% CI 75-78), with a median EPIC-26 incontinence domain score of 100 (interquartile range [IQR] 86-100). At 12 mo, 65% were pad-free (904/1388; 95% CI 63-68%) and 42% were leak-free and pad-free (583/1388; 95% CI 39-45%), with a median EPIC-26 score of 76 (IQR 61-100). While one in three men reported wearing a pad at 12 mo, fewer than one in ten men needed more than 1 pad/d. At baseline, 1.9% reported a "moderate or big problem"with urine leakage, which increased to 9.7% at 12 mo. At baseline, the median sexual domain score among 1880 men was 74 (IQR 43-92) and 52% had erections sufficient for intercourse without medication (975/1880; 95% CI 50-54%). Among these 975 men, 630 responded at 12 mo, of whom 17% reported sufficient erections for intercourse (105/630; 95% CI 14-20%), without medication in 6% (37/630; 95% CI 4-8%) and needing medication in 11% (68/630; 95% CI 9-13%); the median EPIC-26 domain score was 26 (IQR 13-57). Conclusions and clinical implications: Reporting of functional outcomes after RP in terms of easily understood concepts such as pad-free and leak-free status, and erections with and with medication, alongside the classical report using EPIC-26 domain scores, increases the understanding of RP recovery patterns over the first year. Patient summary: At 12 months after surgery for prostate cancer, one in ten men reported a moderate or big problem with urine leakage and one in five men reported sufficient erections. (c) 2024 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology. This is an open access article under the CC BY license (http://creativecommons. org/licenses/by/4.0/).
引用
收藏
页码:11 / 21
页数:11
相关论文
共 16 条
[1]  
Abuelnaga M, 2021, EUR UROL, V79, pS1621
[2]   Prediction of Erectile Function Following Treatment for Prostate Cancer [J].
Alemozaffar, Mehrdad ;
Regan, Meredith M. ;
Cooperberg, Matthew R. ;
Wei, John T. ;
Michalski, Jeff M. ;
Sandler, Howard M. ;
Hembroff, Larry ;
Sadetsky, Natalia ;
Saigal, Christopher S. ;
Litwin, Mark S. ;
Klein, Eric ;
Kibel, Adam S. ;
Hamstra, Daniel A. ;
Pisters, Louis L. ;
Kuban, Deborah A. ;
Kaplan, Irving D. ;
Wood, David P. ;
Ciezki, Jay ;
Dunn, Rodney L. ;
Carroll, Peter R. ;
Sanda, Martin G. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (11) :1205-1214
[3]   Evaluation of Patient- and Surgeon-Specific Variations in Patient-Reported Urinary Outcomes 3 Months After Radical Prostatectomy From a Statewide Improvement Collaborative [J].
Auffenberg, Gregory B. ;
Qi, Ji ;
Dunn, Rodney L. ;
Linsell, Susan ;
Kim, Tae ;
Miller, David C. ;
Tosoian, Jeffrey ;
Sarle, Richard ;
Johnston, William K., III ;
Kleer, Eduardo ;
Ghani, Khurshid R. ;
Montie, James ;
Peabody, James .
JAMA SURGERY, 2021, 156 (03)
[4]   Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study [J].
Donnelly, David W. ;
Vis, Linda C. ;
Kearney, Therese ;
Sharp, Linda ;
Bennett, Damien ;
Wilding, Sarah ;
Downing, Amy ;
Wright, Penny ;
Watson, Eila ;
Wagland, Richard ;
Cross, William R. ;
Mason, Malcolm D. ;
Siesling, Sabine ;
van Manen, Jeannette G. ;
Glaser, Adam W. ;
Gavin, Anna .
BMC CANCER, 2019, 19 (01)
[5]   Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study [J].
Downing, Amy ;
Wright, Penny ;
Hounsome, Luke ;
Selby, Peter ;
Wilding, Sarah ;
Watson, Eila ;
Wagland, Richard ;
Kind, Paul ;
Donnelly, David W. ;
Butcher, Hugh ;
Catto, James W. F. ;
Cross, William ;
Mason, Malcolm ;
Sharp, Linda ;
Weller, David ;
Velikova, Galina ;
McCaughan, Eilis ;
Mottram, Rebecca ;
Allen, Majorie ;
Kearney, Therese ;
McSorley, Oonagh ;
Huws, Dyfed W. ;
Brewster, David H. ;
McNair, Emma ;
Gavin, Anna ;
Glaser, Adam W. .
LANCET ONCOLOGY, 2019, 20 (03) :436-447
[6]   Addressing Missing Data in Patient-Reported Outcome Measures (PROMS): Implications for the Use of PROMS for Comparing Provider Performance [J].
Gomes, Manuel ;
Gutacker, Nils ;
Bojke, Chris ;
Street, Andrew .
HEALTH ECONOMICS, 2016, 25 (05) :515-528
[7]   Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study) [J].
Lane, Janet Athene ;
Donovan, Jenny L. ;
Young, Grace J. ;
Davis, Michael ;
Walsh, Eleanor, I ;
Avery, Kerry N. L. ;
Blazeby, Jane M. ;
Mason, Malcolm D. ;
Martin, Richard M. ;
Peters, Tim J. ;
Turner, Emma L. ;
Wade, Julia ;
Bollina, Prasad ;
Catto, James W. F. ;
Doherty, Alan ;
Gillatt, David ;
Gnanapragasam, Vincent ;
Hughes, Owen ;
Kockelbergh, Roger ;
Kynaston, Howard ;
Oxley, Jon ;
Paul, Alan ;
Paez, Edgar ;
Rosario, Derek J. ;
Rowe, Edward ;
Staffurth, John ;
Neal, David E. ;
Hamdy, Freddie C. ;
Metcalfe, Chris .
BJU INTERNATIONAL, 2022, 130 (03) :370-380
[8]  
National Prostate Cancer Audit. Reports, NPCA annual report 2022
[9]   Hospital volume and outcomes after radical prostatectomy: a national population-based study using patient-reported urinary continence and sexual function [J].
Nossiter, Julie ;
Morris, Melanie ;
Cowling, Thomas E. ;
Parry, Matthew G. ;
Sujenthiran, Arunan ;
Aggarwal, Ajay ;
Payne, Heather ;
van der Meulen, Jan ;
Clarke, Noel W. ;
Cathcart, Paul .
PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) :264-270
[10]   Comparison of the treatment of men with prostate cancer between the US and England: an international population-based study [J].
Parry, Matthew G. ;
Nossiter, Julie ;
Morris, Melanie ;
Sujenthiran, Arunan ;
Skolarus, Ted A. ;
Berry, Brendan ;
Nathan, Arjun ;
Cathcart, Paul ;
Aggarwal, Ajay ;
van der Meulen, Jan ;
Trinh, Quoc-Dien ;
Payne, Heather ;
Clarke, Noel W. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (02) :287-292